-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
All provinces, autonomous regions, municipalities directly under the Central Government and the Xinjiang Production and Construction Corps Joint Prevention and Control Mechanism (Leading Group and Headquarters), Administration of Traditional Chinese Medicine, and Administration of Drug Administration:
In order to strengthen the management of the use of preparations prepared by children's medical institutions during the epidemic, promote graded diagnosis and treatment, and further meet the needs of children for medical treatment and medication, the relevant work notice is hereby notified as follows:
1.
In accordance with the Drug Administration Law of the People's Republic of China and its relevant provisions, preparations prepared by children's medical institutions that have been approved or filed in accordance with the law with the approval of the provincial drug regulatory department may be transferred and used
between designated medical institutions within their jurisdiction.
In accordance with the Drug Administration Law of the People's Republic of China and its relevant provisions, preparations prepared by children's medical institutions that have been approved or filed in accordance with the law with the approval of the provincial drug regulatory department may be transferred and used
between designated medical institutions within their jurisdiction.
2.
Medical establishments shall carefully evaluate and select preparations prepared by medical institutions for children with precise efficacy, controllable quality, safety and stability for transfer and use
.
Medical establishments shall carefully evaluate and select preparations prepared by medical institutions for children with precise efficacy, controllable quality, safety and stability for transfer and use
.
3.
The provincial-level drug regulatory department shall carry out rapid examination and approval of applications for the transfer and use of preparations prepared by medical institutions for children, and in principle shall complete the examination and approval
within 3 working days.
The provincial-level drug regulatory department shall carry out rapid examination and approval of applications for the transfer and use of preparations prepared by medical institutions for children, and in principle shall complete the examination and approval
within 3 working days.
4.
Medical establishments shall bear the main responsibility for the quality of the preparations prepared by the medical institutions they transfer and use, strengthen the guidance of pharmaceutical affairs management for the medical institutions receiving the transfer, strengthen the training of medical personnel, so that they can master the indications, contraindications, dosage and common adverse reactions of the transferred preparations, and strengthen monitoring to ensure the safety
of medication.
Medical institutions receiving the transfer shall use the preparation in strict accordance with the instructions, and bear responsibility
for the adverse consequences caused by excessive use or improper use.
Medical establishments shall bear the main responsibility for the quality of the preparations prepared by the medical institutions they transfer and use, strengthen the guidance of pharmaceutical affairs management for the medical institutions receiving the transfer, strengthen the training of medical personnel, so that they can master the indications, contraindications, dosage and common adverse reactions of the transferred preparations, and strengthen monitoring to ensure the safety
of medication.
Medical institutions receiving the transfer shall use the preparation in strict accordance with the instructions, and bear responsibility
for the adverse consequences caused by excessive use or improper use.
V.
All types of medical institutions at all levels should continuously strengthen the management of pharmaceutical affairs, promote the rational use of drugs in clinical practice, and effectively ensure the quality and safety
of medical treatment.
The competent health departments, traditional Chinese medicine departments and drug regulatory departments should strengthen the supervision and management of the work of medical institutions to prepare preparations and transfer the use of preparations, and ensure that relevant work is carried out
in a standardized and orderly manner.
All types of medical institutions at all levels should continuously strengthen the management of pharmaceutical affairs, promote the rational use of drugs in clinical practice, and effectively ensure the quality and safety
of medical treatment.
The competent health departments, traditional Chinese medicine departments and drug regulatory departments should strengthen the supervision and management of the work of medical institutions to prepare preparations and transfer the use of preparations, and ensure that relevant work is carried out
in a standardized and orderly manner.
The State Council's response to the novel coronavirus pneumonia epidemic was carried out by the State Administration of Traditional Chinese Medicine
Comprehensive Department of the Medical Treatment Group of the Joint Prevention and Control Mechanism
State Drug Administration
Integrated Division
December 15, 2022
